Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?

Journal of Endocrinological Investigation

Volumn 23, Issue 7, 2000, Pages 457-462

  Palermo, M ^a   Delitala, G ^a   Sorba, G ^a   Cossu, M ^a   Satta, R ^a   Tedde, R ^a   Pala, A ^a   Shackleton, C H L ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

11 HSD deficiency; AME syndrome; Apparent mineralocorticoid excess syndrome; Cortisol metabolism; Kidney transplantation; Low renin hypertension

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ATENOLOL; CORTISONE; CORTISONE ACETATE; DEXAMETHASONE; ENALAPRIL; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; NIFEDIPINE; POTASSIUM;

ADULT; ARTICLE; CASE REPORT; DIALYSIS; DOSE RESPONSE; DRUG INHIBITION; FEMALE; HORMONE RECEPTOR INTERACTION; HUMAN; HYDROCORTISONE RELEASE; HYPERALDOSTERONISM; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; SODIUM RETENTION; STEROID METABOLISM;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADULT; BLOOD PRESSURE; CORTISONE; FEMALE; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; HYPERTENSION; ISOENZYMES; KIDNEY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; POTASSIUM; RECEPTORS, MINERALOCORTICOID; RENIN; SYNDROME; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

EID: 0033824524     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343755     Document Type: Article

References (15)

1. 11-Hydroxysteroid dehydrogenase
2. Apparent mineralocorticoid excess syndrome
3. 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess
4. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor
5. Cure of apparent mineralocorticoid excess by kidney transplantation
6. A new form of the syndrome of apparent mineralocorticoid excess
7. Apparent mineralocorticoid excess: Type I and type II
8. Molecular basis for hypertension in the 'type II variant' of apparent mineralocorticoid excess
9. Treatment of acute rejection in live related renal allograft recipients: A comparison of three different protocols
10. Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research
11. Quantitation of cortisol and related 3-oxo-4-ene steroids in urine using gas chromatography/mass spectrometry with stable isotope-labeled internal standards
12. The hypertension of apparent mineralocorticoid excess (AME) syndrome
13. Plasma cortisol delivery from oral cortisol and cortisone acetate: Relative bioavailability
14. Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man
15. 11β-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: Explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome